Genevieve Weir

Genevieve Weir

Company: IMV Inc.

Job title: Head of Business Development


The DPX Delivery Platform Enables Cancer Vaccines to be Clinically Viable 10:30 am

DPX is a unique lipid-in-oil, non-emulsion delivery formulation that educates a targeted and long-lasting immune response in regional lymph nodes DPX can be formulated to deliver a variety of cargo (e.g. peptides, proteins, VLPs, TLRs, mRNA) Proof of concept is clinically demonstrated in several hematologic and solid cancer indicationsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.